-
When Less Is More
Studies are finding that aggressive treatment, such as extensive surgery, radiation or chemotherapy, is not always necessary for cancer patients to get good results.
by Alexandra Goho
-
No Through Road
Cancer cells are able to find new pathways around targeted therapies. Scientists are racing to get there first.
by Sue Rochman
-
Healthy Habits
It Takes All KindsA variety of vegetables and fruit can help reduce your cancer risk
by Marci A. Landsmann
-
Forward Look
Telling the TaleQ&A with medical oncologist Siddhartha Mukherjee, the Pulitzer Prize-winning author of The Emperor of All Maladies.
by Sue Rochman
-
Forward Look
The Proof of the Proton Is in the ResultProton beam radiation therapy is expensive and controversial.
by Stephen Ornes
-
Forward Look
The Whole BeanStudies present a mixed picture of coffee's influence on cancer risk.
by Yvonne Lee
-
Forward Look
Melanoma Indoor Tanning Link ConfirmedTeens and young adults face heightened risk from tanning beds.
by Yvonne Lee
-
Forward Look
A Paycheck Linked to Cancer?Studies on workplace exposures show continued health risks.
by Corinna Wu
-
When Cancer Rings Twice
One out of every six people diagnosed with cancer this year will be facing it for, at least, the second time.
by Melissa Weber
-
Changing the Face of Clinical Trials
Efforts are under way to increase African-American enrollment in cancer clinical trials.
by Leslie Harris O'Hanlon
Cancer Talk
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
Understanding Stress and CancerA symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
Study Shows Minority Participation in Clinical Trials May Be DecliningResearcher speculates that costly genetic testing may be limiting outreach to underserved communities.
by Marci A. Landsmann
